CorMedix Inc. (CRMD) is a publicly traded Healthcare sector company. As of November 6, 2026, CRMD trades at $5.27 with a market cap of $441.16M and a P/E ratio of 3.10. CRMD moved +0.76% today. Year to date, CRMD is -57.14%; over the trailing twelve months it is -53.18%. Its 52-week range spans $5.22 to $17.43. Analyst consensus is strong buy with an average price target of $14.60. Rallies surfaces CRMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for CRMD combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $5.27 |
| Market Cap | $441.16M |
| P/E Ratio | 3.10 |
| EPS | $2.36 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.43 |
| 52-Week Low | $5.22 |
| Volume | 8.09K |
| Avg Volume | 0 |
| Revenue (TTM) | $462.25M |
| Net Income | $187.17M |
| Gross Margin | 82.78% |
5 analysts cover CRMD: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $14.60.